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Abstract
Aging is a multi-factorial process, however, it is generally accepted that reactive oxygen species (ROS) are significant
contributors. Mitochondria are important players in the aging process because they produce most of the cellular ROS.
Despite the strength of the free-radical hypothesis, the use of free radical scavengers to delay aging has generated mixed
results in vertebrate models, and clinical evidence of efficacy is lacking. This is in part due to the production of pro-oxidant
metabolites by many antioxidants while scavenging ROS, which counteract their potentially beneficial effects. As such, a
more effective approach is to enhance mitochondrial metabolism by reducing electron leakage with attendant reduction of
ROS generation. Here, we report on the actions of a novel endogenous indole derivative, indolepropionamide (IPAM), which
is similar in structure to melatonin. Our results suggest that IPAM binds to the rate-limiting component of oxidative
phosphorylation in complex I of the respiratory chain and acts as a stabilizer of energy metabolism, thereby reducing ROS
production. IPAM reversed the age-dependent decline of mitochondrial energetic capacity and increased rotifer lifespan,
and it may, in fact, constitute a novel endogenous anti-aging substance of physiological importance.
Citation: Poeggeler B, Sambamurti K, Siedlak SL, Perry G, Smith MA, et al. (2010) A Novel Endogenous Indole Protects Rodent Mitochondria and Extends Rotifer
Lifespan. PLoS ONE 5(4): e10206. doi:10.1371/journal.pone.0010206
Editor: Mikhail V. Blagosklonny, Roswell Park Cancer Institute, United States of America
Received December 3, 2009; Accepted March 4, 2010; Published April 21, 2010
Copyright:  2010 Poeggeler et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Work in the authors’ laboratories is supported by the Alzheimer’s Association (Zenith Award to MAP; IIRG-09-132087 to MAS), the National Institutes of
Health (AG022103, AG10483, and AG023055 to MAP and KS; AG028679 to MAS), and the German Research Foundation DFG (Deutsche Forschungsgemeinschaft
PO 662/1-1 to BP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: sambak@musc.e (KS); pappolla@aol.com (MAP)
. These authors contributed equally to this work.
Introduction
The reasons for the failure of antioxidant therapies in AD may
be multiple, but toxic, pro-oxidant intermediates generated from
many such compounds can reverse their beneficial effects and
have been demonstrated to be partly responsible for the failure [1].
Consequently, administration of reactive antioxidants like vitamin
E have resulted in unexpectedly unfavorable clinical outcomes [2].
Another frequent reason for failure is lack of ‘‘on-site protection’’,
a consequence of limited bioavailability.
Despite the strength of the free-radical hypothesis, the use of
free radical scavengers to delay aging has generated mixed results
in vertebrate models, and clinical evidence of efficacy is lacking
[3]. We previously showed that this may be due, in part, to the
production of pro-oxidant metabolites by many antioxidants while
scavenging ROS, which counteract their potentially beneficial
effects [1]. As such, a more effective approach is to enhance
mitochondrial metabolism by reducing electron leakage with
attendant reduction of ROS generation [4].
Mitochondria are important players in the aging process
because they produce most of the cellular reactive oxygen species
(ROS) [5–7]. These organelles are the main source of most free-
radicals generated by cells and defects in energy metabolism have
implicated these organelles in various neurodegenerative diseases
and in aging [8,9]. It has been proposed that in aging, a vicious
cycle can occur in which increased oxidative stress leads to
persistent mitochondrial dysfunction and severe energy depletion
[9,10].
We have previously hypothesized that such damage can either
be attenuated or reversed by compounds that act as mobile
electron and proton carriers [11]. Some indole substances are
capable of supporting electron flux through the respiratory chain,
preventing the breakdown of the mitochondrial membrane
potential, and decreasing electron leakage, and they thereby
reduce the formation of free-radicals [12]. In addition, certain
indoles may be potent anti-oxidants via their involvement in
single-electron transfer reactions that lack pro-oxidant intermedi-
ates [8,12]. In 1999, we reported that a substance related to
melatonin, indole-3-propionic acid (IPA) may be the most potent
naturally occurring hydroxyl radical scavenger in neutralizing
free-radicals by electron donation [1]. However, IPA is hydro-
philic and has limited bioavailability, which raises doubts as to the
physiological relevance of this molecule. In order to overcome this
problem, we designed, by introducing an amide group to IPA, an
amphiphilic indole substance (indolepropionamide; IPAM) which
has a higher bioavailability. After synthesizing IPAM, we
discovered that it existed as a naturally occurring substance.
Further, because we reported that certain indoles neutralized free
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on the mitochondrial membrane potential, the proton motive
force that drives ATP synthesis, in preparations from rat brain of
young and old animals. We also tested whether IPAM could
prevent and protect against the deleterious effects of specific
mitochondrial toxins.
Materials and Methods
High performance liquid chromatography (HPLC)
HPLC with fluorometric detection was carried out on
supernatants of rat brain samples that were homogenized in
0.4 N perchloric acid (PCA) including as additives 0.1% EDTA
and 0.05% Na2S2O5. The mobile phase consisted of 20%
methanol, 30 mM NaH2PO4, 50 mM citric acid, 2 mM octane-
sulfonic acid and 0.1 mM EDTA at a flow rate of 0.5 ml/minute.
Synthesis of IPAM
IPAM had initially been produced as follows: a mixture of 30 g
of indole-3-propionic acid and 10 ml of methanesulfonic acid in
200 ml of ethanol was stirred for 24 hours, poured into water, and
extracted with ethylacetate. The ethylacetate solution was washed
with NaHCO3 solution and water and dried over magnesium
sulfate. A solution of 800 mg of the crude product (indole-3-
propionic acid ethyl ester) and 2 ml of hydrazine in 20 ml of
ethanol was refluxed for 18 hours, and extracted with ethylacetate.
The organic phase was washed with brine, dried over magnesium
sulfate, and evaporated at reduced pressure to give with 93% yield
the intermediate propanoic acid hydrazide as a solid. This
material and 0.3 g of Raney nickel catalyst (W-4) in 25 ml of
ethanol were refluxed for 2.5 hours. The solution was decanted
and evaporated at reduced pressure and the residue chromato-
graphed on silicia gel, eluting with ethylacetate, to give with 96%
yield indole-3-propionamide.
Mitochondrial preparations and measurement of
membrane potentials
Mitochondria were prepared and maintained as described in
detail [13]. Mitochondrial membrane potential was determined by
measuring rhodamine 123 fluorescence quenching after respira-
tion-driven uptake of the dye by mitochondria of the rat brain
preparations in 6 mM malate and 6 mM glutamate for 30
minutes. Rhodamine fluorescence was monitored in real time as
previously described [14]. The negative mitochondrial membrane
potential was calculated by using the Nernst-Guggenheim
equation: Dy=59 log ([rhodamine]in/[rhodamine] out), accord-
ing to Scaduto and Grotyohann [15].
To examine potential interactions between IPAM and mito-
chondrial complexes, sub-mitochondrial preparations were ob-
tained according to published methods [16] to measure the specific
activity of mitochondrial oxidative complexes, where intact
mitochondria were harvested and maintained as described in
detail [13]. The protocols of Durand et al. [17] were used for all
incubation conditions to determine the effects of IPAM on energy
metabolism using mitochondria or sub-mitochondrial particles. In
addition, IPAM binding to complex I was determined by
displacement of known ligand inhibitors to this complex. For this
purpose, the methods of Brenner-Lavie et al. [18] and Yuan and
Pang [19] were employed to determine [
3H]-dopamine and 2-
[
125I]-iodomelatonin displacement by IPAM over a large concen-
tration range.
The specific activity of the mitochondrial oxidative complexes
was determined using sensitive assays as described by Martin et al.
[16,20] at an incubation temperature of 37.5uC. Mice brain
mitochondria preparations from young and old animals (male
Swiss Webster mice, n=6) were used, demonstrating again the
effects of aging, melatonin and IPAM at concentrations of 10 nM.
Sub-mitochondrial particles from mouse brain were incubated
with a solution containing nitroblue tetrazolium (NBT) at 0.1% in
working buffer for 30 minutes at an incubation temperature of
37.5uC in an oscillating water bath. The NBT reduction assay [21]
was carried out in the presence of 100 Units of superoxide
dismutase (SOD) to prevent non-specific reduction of the
tetrazolium dye by superoxide anion radicals generated during
the incubation. Control experiments with the specific complex I
inhibitors capsaicin and dopamine as described above were carried
out to assure that more than 80% of NBT reduction was due to
specific reduction of the dye as an alternate electron and proton
acceptor at the mitochondrial iron sulfur cluster N2 in complex I.
Termination of the assay and extraction of the reduced dye was
carried out by centrifugation of the mitochondrial preparations at
2000 g for 10 minutes. The supernatant was decanted and the
pellet was resuspended in 1 ml glacial acetic acid. The relative
absorbance of the glacial acetic acid fraction was measured at
570 nm to calculate the amount of reduced diformazan formed
during the incubation by reduction of the tetrazolium dye using a
standard curve generated with synthetic nitroblue diformazan.
Figure 1. Fluorometric HPLC detection of IPAM, melatonin and
IPA in the brain of one-month-old male Sprague-Dawley rats:
Peaks with identical elution times as synthetic IPAM, melato-
nin and IPA were consistently observed in rat brain. a) One hour
after administration of 300 mg/kg L-tryptophan, IPAM (1), melatonin (2)
and indole-3-propionic acid (3) concentrations reached levels of 34669
(IPAM), 713632 (MEL) and 281614 (IPA) pg indole/mg protein,
respectively, in rat brain (n=6). b) Co-elution of the endogenous
indoles IPAM, melatonin and IPA along with the standards of these
indole compounds results in larger single elution peaks representing
endogenous plus exogenous indoles. c) Synthetic IPAM standard (1 ng)
eluted at 30 minutes. Inset shows predicted structure of synthetic IPAM.
doi:10.1371/journal.pone.0010206.g001
IPAM Protection in Rat Brain
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SEM) measured in rat brain mitochondria from young and old animals (male Sprague-Dawley rats, n=6) with effects of melatonin, IPA and IPAM at
10 nM. All compounds were significantly different from control at both 1 month and 20 months, with IPAM showing significantly greater effects than
melatonin or IPA. a- significantly different from control (p,0.0005); b- significantly different from melatonin and IPA (p,0.01).
doi:10.1371/journal.pone.0010206.g002
Figure 3. Mitochondrial membrane potential in mV: Effects of age, toxins and IPAM. Mitochondrial membrane potential in mV (mean 6
SEM) was measured in rat brain mitochondria from young and old animals (male Sprague-Dawley rats, N=6). The toxins doxorubicin (DOX),
antimycin A (AmA) and FCCP at concentrations of 500 nM led to significant reductions in membrane potential as compared to control. Co-
administration of IPAM at 10 nM significantly antagonized the effects of each toxin. In fact, the toxicity of doxorubicin and antimycin A was
completely abrogated by IPAM to levels comparable to control. a- significantly different from control (p,0.05); b-significantly different from control
(p,0.001); c- significantly different from toxin only (p,0.05); d-significantly different from toxin only (p,0.005).
doi:10.1371/journal.pone.0010206.g003
IPAM Protection in Rat Brain
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indoles
The test compounds and salicylate were incubated at a
concentration of 0.1 mM in the presence of 1 mM hydrogen
peroxide, 0.1 mM FeCl3 and 1 mM EDTA. The hydroxyl radical
adducts of salicylate, 2,3-DHBA, and 2,5-DHBA were measured
by HPLC-ECD. The measurements are expressed as a percentage
of control and represent the means 6 SEM from 6 independent
experiments.
Inhibition of hydroxyl radical mediated oxidative damage by
IPAM compared with related indole antioxidants in rat forebrain
homogenate shows that IPAM was very powerful preventing OHN
mediated DNA damage. Rat forebrain homogenate was incubated
for sixty minutes with 3 mM hydrogen peroxide, 4 mM ferrous
sulfate, and 2 mM ADP to generate hydroxyl radicals. The IC50
values (concentrations of each indole compound required to
reduce oxidative DNA damage by 50%) are given as means +
standard deviations for N=6 different determinations. The IC50
values were calculated by performing six experiments each at
increasing concentrations ranging from 0.01 to 100 mM melato-
nin, indole-3-propionic acid, and IPAM. DNA damage was
examined by measuring the formation of 8-hydroxydeoxyguano-
sine by a sensitive HPLC method applying electrochemical
detection in the presence and absence of the hydroxyl radical
scavengers.
Animal experiments
Sprague-Dawley rats, aged 1 month (n=6) and 20 months
(n=6) were maintained according to the approved institutional
protocols. Upon sacrifice, animals were euthanized and brains
removed. Mitochondria were isolated as previously described (13).
Mitochondria were also prepared from young (3 month, n=6) and
old (18 months, n=6) male Swiss Webster mice, which were
maintained using approved protocols. All animals were strictly
handled and sacrificed according to humane protocols reviewed
and approved by the MUSC Institutional Animal Care & Use
Committee, which is part of the MUSC Office of Research
Integrity.
Rotifer experiments
The rotifers were housed in individual isolation cultures of
defined and uniform age as described previously in detail [11].
Results
We designed, by introducing an amide group to IPA, an
amphiphilic indole substance (IPAM), and its predicted structure is
shown in Figure 1, inset. After synthesizing IPAM, we discovered
that it existed as a naturally occurring substance. Endogenous
IPAM (Figure 1a). eluted with an identical retention time as
synthetic IPAM (Figure 1c) by HPLC Initially, peaks correspond-
ing to endogenous IPAM were inconsistent and could not be
accurately quantified due to their very low basal concentrations
which, in rat brain tissue were estimated to be below 100 pg
indole/mg protein. In order to increase the sensitivity of our
method and to avoid potential artifacts, we pursued an established
strategy for indole detection consisting of administering an oral
load of tryptophan, the aromatic amino-acid precursor of indoles.
To further confirm the observation in 1a, synthetic IPAM,
melatonin and IPA (1 ng of each compound/mg protein) were
added to tissue samples prepared in parallel (containing the
endogenous indoles in the tissue at levels as depicted in Figure 1a)
and the samples were analyzed by HPLC (Figure 1b). One hour
after administration of 300 mg/kg L-tryptophan to 1 month old
male Sprague-Dawley rats, we observed that IPAM, melatonin
and indole-3-propionic acid concentrations could be reproducibly
measured as shown in Figure 1 at increased levels of 34669
(IPAM), 713632 (MEL) and 281614 (IPA) pg indole/mg protein
in rat brain (n=6).
Figure 4. Activity of mitochondrial complex I and IV: Effects of
age and indole agents on ferric cyanide reduction and
cytochrome c oxidation. The activities of mitochondrial complex I
(A) and complex IV (B) expressed in mmol/min/mg protein (mean 6 SEM)
were measured in mice brain mitochondrial preparations from young
and old animals (male Swiss Webster mice, n=10). Melatonin and IPAM
were used at 10 nM concentration. Only IPAM consistently significantly
increased complex I and IV activities compared to control. The results for
complex I were verified by a second method in which the activity of the
mitochondrial iron sulfur cluster N2 in complex I was determined by the
nitroblue tetrazolium (NBT) reduction assay as mmol diformazan formed/
minute/mg of mitochondrial protein (mean 6 SEM) (C). a-significantly
different from control (p,0.05); b-significantly different from control
(p,0.005); c- significantly different from control (p,0.001).
doi:10.1371/journal.pone.0010206.g004
IPAM Protection in Rat Brain
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samples analyzed at 2, 4 and 8 hours after intraperitoneal
administration of synthetic IPAM (n=6), melatonin (n=6) or
IPA (n=6) to 1 month old male Sprague-Dawley rats. Intraper-
itoneal administration of 0.5 mg/kg melatonin or 0.5 mg/kg IPA
did not increase the barely-detectable baseline levels of these
indoles in rat brain. In contrast, IPAM given at the same dose
resulted in high brain levels of IPAM of 691623 at 2 hours,
562613 at 4 hours and 361612 pg indole/mg protein at 8 hours
(n=6, mean 6 SEM).
The effect of age and added indole agents on mitochondrial
membrane potential was measured. A pronounced age-dependent
decline in proton motive force and energetic capacity of untreated
mitochondria was seen. Notably, these age-related effects were
antagonized by administration of IPAM, melatonin and IPA
(Figure 2).
The effectiveness of IPAM to prevent and protect against the
deleterious effects of specific mitochondrial toxins in doxorubicin,
antimycin A employed to inhibit electron transport, and
carbonylcyanide-p-trifluoromethoxyphenylhydrazone (FCCP) to
dissipate the proton potential, was determined. All three
mitochondrial toxins, including FCCP, were able to induce a
collapse of the mitochondrial proton potential. IPAM markedly
reduced the proton potential collapse induced by the mitochon-
drial toxins to nearly baseline levels in both young and old rats
(Figure 3).
IPAM, and melatonin to a lesser extent, can increase complex I
and complex IV activity in the mitochondrial electron transport
chain (Figures 4A,B). The results for complex I were verified by a
second method in which the activity of the mitochondrial iron
sulfur cluster N2 in complex I was determined by the NBT
reduction assay as mmol diformazan formed/minute/mg of
mitochondrial protein (mean 6 SEM) (Figure 4C). No significant
changes were seen in the activity of complex II to III (data not
shown). Highly efficient and specific displacements of both ligands
from their endogenous mitochondrial binding sites were also
demonstrated (data not shown).
To assay for anti- and pro-oxidant activity, a hydroxyl radical-
generating system consisting of hydrogen peroxide, iron, and
EDTA was employed as described previously [1]. IPAM was the
most potent antioxidant compound in reducing the formation of
hydroxyl radicals and like IPA, it did not elicit any pro-oxidant
reactive intermediates in vitro (Figure 5). On the other hand, closely
related indole compounds such as the melatonin precursor
serotonin and the melatonin metabolite 6-hydroxymelatonin, as
well as the indolepropionic acid analogue 5-methoxyindoleacetic
acid used as controls in the experiments, were also pro-oxidant
and increased hydroxyl radical formation in this assay system.
Inhibition of hydroxyl radical mediated oxidative damage by
IPAM compared with related indole antioxidants in rat forebrain
homogenate shows that IPAM attenuates OHN mediated DNA
damage and the formation of 8-hydroxydeoxyguanosine. The IC50
values (concentrations of each indole compound required to
reduce oxidative DNA damage by 50%) were determined to be
1.460.16 mM for melatonin, 7.4660.80 mM for indole-3-propio-
nic acid, and 0.1860.03 mM for IPAM.
We then used IPAM to test the hypothesis that free radicals may
contribute to the aging process in a rotifer model of aging. For
these experiments, we used the Bdelloid rotifer Philodina
acuticornis odiosa Milne. IPAM was used at concentrations of
10, 20 and 30 mM (Figure 6A). Administration of IPAM resulted
in significant life extension in the rotifers, even exceeding 300% at
the highest concentration used. Mean lifespan of rotifers (n=11,
mean 6 SEM) increased from 24.661.8 days (Control) to
58.563.3 days (10 mM IPAM), 81.163.7 days (20 mM IPAM)
and 90.563.8 days (30 mM IPAM). To the best of our knowledge,
this is the most pronounced life extension ever recorded in this
experimental model or in similar organisms like C. elegans [11].
An unexpected finding was that IPAM treated rotifers were of
larger size than rotifers of the same age exposed to control vehicle
solution (Figure 6B,C,D), suggesting a growth promoting function
for IPAM. The average rotifer length determined on day 15 of
treatment (n=10, mean 6 SEM) was increased from 390 mm
65 mm (control, vehicle treatment) to 575 mm 66 mm (IPAM
treatment). With increase in longevity, the fertility of the rotifers
was also increased as measured by offspring number per parent as
observed in individually housed rotifiers. In particular, the total
number of viable offspring per rotifer during a lifetime rose from
Figure 5. Pro- and antioxidant effects of indole agents expressed as hydroxyl radical adducts of salicylate (percentage of control, no
test agent added). Pro- and antioxidant effects of indole agents as demonstrated as percentage of hydroxyl radical adducts formed from salicylate
oxidation to 2,3- and 2,5-dihydroxybenzoic acids (DHBAs) versus control (incubation system without test agents: 10062.8%, mean 6 SEM, n=6).
doi:10.1371/journal.pone.0010206.g005
IPAM Protection in Rat Brain
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rotifers to an average of 55 animals 61 animal after daily
treatment with 30 mM IPAM in single-housed organisms (n=10).
When treated with lower doses of 10 and 20 mM IPAM, the
individually housed rotifers had a total number of 5262 and 5362
offspring on average (Figure 6E). IPAM also increased the
duration of the reproductive period per rotifer (fertile days in
culture during a lifetime) to 1861 day(s) for the IPAM treated
organisms, up from 561 day(s) in controls (n=10). The duration
of the reproductive period per animal, as measured in the number
of fertile days for each rotifer in single-housed cultures, averaged
1361 and 1661 day(s), when the animals were treated with the
lower dose of IPAM at a concentration of 10 or 20 mM daily
(Figure 6F). The effects on growth and fertility exerted by IPAM
were seen at all concentrations used and were determined to be
statistically significant for the treatment groups (p,0.001; n=10).
Discussion
In contrast to indole-3-propionic acid which bears a polar
carboxyl group that is ionized at physiological pH carrying a
negative charge, IPAM is non-polar and has sufficient lipophilicity
(and amphiphilicity) to penetrate through biological membranes.
In contrast to melatonin, IPAM is a ‘‘reversed amide’’ lacking the
Figure 6. Lifespan extension in rotifers. In rotifers (n=11) IPAM at 10, 20 and 30 mM markedly extended the lifespan of rotifers. These effects
were dose dependent and highly significant at all concentrations tested (p values ,0.001 for all concentrations versus the control group (A). IPAM
treatment of rotifers for 15 days at 30 mM daily resulted in a significantly increased size (B). Representative size differences are illustrated in animals
treated either with vehicle for 15 days (C) or IPAM (D) for 15 days. Magnification X 90. The number of offspring for individual parents (E), as well as the
number of reproductive days (F) during lifetime was significantly increased with IPAM (n=10). a- significantly different from control (p,0.0001).
doi:10.1371/journal.pone.0010206.g006
IPAM Protection in Rat Brain
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metabolized in the liver by hydroxylation in the para position to its
large side chain (extensive first liver pass effect with rapid
clearance) and excreted as the glucuronide or sulfate conjugate
of 6-hydroxymelatonin (a pro-oxidant metabolite). IPAM, howev-
er, has a long half-life and no pro-oxidant activity (Figure 5), thus
the metabolism of IPAM will be an important topic for additional
investigation. Significantly, IPAM is found within the brain
(Figure 1) and may be able to protect against oxidative damage,
especially to mitochondria.
Severe mitochondrial dysfunction and ATP deprivation is seen
in aging cells and organisms [10,11,14,22–24]. The main sites in
the mitochondrial electron transport chain at which free-radicals
are produced are not fully elucidated, although at least 50% of the
total free-radicals generated by mitochondria are attributed to
dysfunction of complex I [25], which is in itself highly vulnerable
to oxidative stress. Complex I is embedded into the inner
mitochondrial membrane and serves to dehydrogenate NADH
and shuttle electrons to coenzyme Q. This electron transport
mechanism generates a gradient across the inner mitochondrial
membrane, which provides the proton-motive force that is used in
ATP synthesis. While IPA and melatonin protected against
mitochondrial damage in both young (1 month) and older (20
months) rats, IPAM provided significantly greater protection
(Figure 2).
To further test the effect on mitochondria, three mitochondrial
toxins, including FCCP, were used to induce a collapse of the
mitochondrial proton potential resulting in severe mitochondrial
dysfunction and ATP deprivation as seen in senescent cells and
organisms [10,11,14,22–24]. The addition of IPAM significantly
protected mitochondria function against the toxic action of all
three compounds (Figure 3). IPAM was shown to have a direct
effect on both the Complex I and Complex IV activities (Figure 4).
Decreased activity of these complexes results in an inhibition of
electron transport that is associated with higher production of
ROS. Taken together, and since the activity of IPAM occurred at
low nM concentrations, these data provide evidence that that
IPAM can also act as a recyclable electron and proton carrier,
facilitating reversible endogenous radical and redox reactions, and
thereby enabling the formation of a proton gradient that drives
mitochondrial ATP synthesis.
Testing the addition of IPAM to a model organism revealed
astonishing results (Figure 6). Increasing concentration of IPAM
resulted in survival rates reaching 300% of control, untreated
rotifers. This increased survival was accompanied by dramatically
increased organism size. Even though rotifers grow throughout
their entire life cycle, the size increase illustrated here was
independent of enhanced longevity. Further, the increased lifespan
allowed for increases both in the total number of reproductive days
as well a three-fold increase in the number of offspring per
individual. The mechanisms involved in these processes remain to
be determined.
Thus, the following conclusions can be drawn from the
experiments: 1) IPAM occurs endogenously and its levels can be
increased after administration of L-tryptophan; 2) IPAM has high
bioavailability as it can efficiently cross the blood brain barrier and
remain at high concentrations in rat brain for several hours; 3)
IPAM levels cannot be increased after administration of IPA or
melatonin; and 4) IPAM may impart anti-aging benefits. The
latter observation may have therapeutic ramifications if one is to
enhance the antioxidant defense systems in mammalian biosys-
tems including the brain.
Similar adverse effects were observed in a prior study showing
pro-oxidant activity for ascorbate (vitamin C), and trolox (a water
soluble derivative of vitamin E) [1]. These findings caution against
the indiscriminate use of antioxidants as cytoprotective agents
which in biological systems can increase free-radical formation.
Such effects may provide an explanation for the adverse clinical
outcomes recently reported with chronic administration of
substances like vitamin E [2]. We also conducted a spectrum of
assays to confirm that IPAM exerted free-radical scavenging
properties as compared to melatonin and other antioxidant indoles
such as IPA. IPAM showed radical reducing activity which
exceeded the potency of melatonin and IPA. Due to the scope of
this report, these data will be presented elsewhere.
In conclusion, we report on a new and naturally occurring
indole, IPAM, which showed its potential as a mitochondrial
metabolism modifier and an anti-aging molecule. Likewise, IPAM
may hold therapeutic potential in age-related neurodegenerative
diseases and in mitochondrial disorders.
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